Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
about
Aristolochic acid-associated urothelial cancer in TaiwanCystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM studyInteractions between kidney disease and diabetes: dangerous liaisonsFRMD3 gene: its role in diabetic kidney disease. A narrative reviewEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyEffect of redox modulating NRF2 activators on chronic kidney diseaseImpact of renal dysfunction on mid-term outcome after transcatheter aortic valve implantation: a systematic review and meta-analysisGenetic and epigenetic factors influencing chronic kidney diseaseRenal insufficiency and cancer treatmentsCrosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney diseaseInflammation gene variants and susceptibility to albuminuria in the U.S. population: analysis in the Third National Health and Nutrition Examination Survey (NHANES III), 1991-1994Subclinical atherosclerosis measures for cardiovascular prediction in CKDPerfluoroalkyl chemicals and chronic kidney disease in US adultsRole of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup.Evolving pandemic diabetic nephropathyImpact of contrast-enhanced ultrasound in patients with renal function impairmentImpact of clinical context on acute kidney injury biomarker performances: differences between neutrophil gelatinase-associated lipocalin and L-type fatty acid-binding proteinA linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.Comparison of concurrent complications of CKD by 2 risk categorization systems.Estimating prevalence of CKD stages 3-5 using health system data.Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.Protein intake and kidney function in the middle-age population: contrast between cross-sectional and longitudinal data.Prognostic impact of renal dysfunction in patients with acute coronary syndrome-role beyond the CHA2 DS2 -VASc score: Data from Taiwan acute coronary syndrome full spectrum registry.Serum Creatinine Back-Estimation in Cardiac Surgery Patients: Misclassification of AKI Using Existing Formulae and a Data-Driven ModelRenal function at hospital admission and mortality due to acute kidney injury after myocardial infarction.Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: data from the UK renal registry.Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).Evaluation of clinical outcomes and renal vascular pathology among patients with lupus.CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES).Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.The usefulness of a free self-test for screening albuminuria in the general population: a cross-sectional surveyRisk factors for chronic kidney disease in Japan: a community-based study.The devil is in the detail - a multifactorial intervention to reduce blood pressure in co-existing diabetes and chronic kidney disease: a single blind, randomized controlled trialMasked hypertension associates with left ventricular hypertrophy in children with CKDSerum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus.Gut microbiome and kidney disease: a bidirectional relationship.Effect of statins on cardiovascular events in patients with mild to moderate chronic kidney disease: a systematic review and meta-analysis of randomized clinical trials.Cumulative effects of hypertension, dyslipidemia, and chronic kidney disease on carotid atherosclerosis in Chinese patients with type 2 diabetes mellitus.
P2860
Q24616582-18222C7C-6B0D-465A-BD5F-50397AD70CE7Q24635177-9DCCE2EF-748E-4469-945B-3B36465E9E4BQ26740630-F4889B81-EAF8-4B33-A940-28E58453F61EQ26771495-42CDF22C-C838-4F5D-9804-62E34AF3864AQ26796261-05CAAECD-A342-48D7-B9A3-5706B6EB6F69Q26827726-C3C574C6-5A53-4C15-9E77-CCCAE23510E8Q27008295-AE373E7F-D7E3-4CA9-930D-88B3E761227AQ27024548-104EA50E-FB65-4E8B-A3D6-84FF4F4E9A74Q28079168-4E8346A5-91EF-4F78-89F2-4FFCEB7CE404Q28080433-8C7E14B0-2919-46F2-A4CF-649D31DDD423Q28384803-F7516074-056B-4B3D-9A0D-615064DBA905Q28386933-1223D01C-0214-47C8-8506-0FE9A6E4B7B7Q28393763-F0C8EEB4-026A-43A7-807B-E6BDC3A08A1FQ28533843-81FD4ECF-1D88-48FF-840B-D15D6EE06D90Q30253084-99D57815-80C1-4145-8A26-53E341A95992Q30352538-C7FBB6D8-4E51-4CF2-988C-3CD11409B177Q30364826-0E1C94F2-E81A-4086-A21E-494E98241DEBQ30381837-2AA8E49E-76C6-4EA6-84D4-87D9E3F4FDF6Q30412608-A2DD9E4A-41D2-420A-BB89-FC4B6E1DED81Q30505759-F58D2B95-11E1-42A9-B85B-16CE6EF29282Q30598417-52F9DB89-E52A-4466-8CAA-C9B800012A46Q30651756-4081185E-D7EF-4C42-BA17-941CCA8A2B20Q30783820-261AD9AF-6699-4A4B-A976-77C92770D43FQ31005750-A7B20A8F-39BF-4CA4-A8F1-9FC21007464EQ31039324-6456FB6C-2C02-4087-9DC5-EA85790CE045Q31059869-926D3E31-19D0-49C0-92E4-B523665A52FBQ33278120-E2ED8295-F658-4BA3-A2BD-BE079DE32B4BQ33357921-D7CF55AA-400B-4314-9DF6-D5DA39E38BCDQ33400371-D70EFC3D-CBB2-46E8-B1C0-F2E464CC53E9Q33410988-26B9F513-00A9-4B36-B863-BB36D9191A1DQ33426615-8940F1F3-E5C4-496D-9275-C84E40DE2CFDQ33509637-3B43EA5F-9E1C-4CB5-8CCF-F4A50A0BAF9AQ33513019-279E6A16-3F19-4907-9825-F93F8966862AQ33523202-BC9028D9-3DB2-4732-A583-56E2563E1001Q33562242-64D3FA47-273C-47AC-A8DA-05E2FA875C80Q33566245-F356A20D-D958-4309-B8DF-E225C1CD4B0BQ33585503-F4588FD2-BD06-4002-80CF-32697388860CQ33586234-EBBC627C-A3F4-42C4-A36C-D242230EF22CQ33588706-ADF96BB2-B360-4190-B9C5-2A45C9679637Q33594358-BBF2E2D8-12CD-4EA7-8E37-916392E90E7C
P2860
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Definition and classification ...... oving Global Outcomes (KDIGO).
@en
Definition and classification ...... ase: Improving Global Outcomes
@nl
type
label
Definition and classification ...... oving Global Outcomes (KDIGO).
@en
Definition and classification ...... ase: Improving Global Outcomes
@nl
prefLabel
Definition and classification ...... oving Global Outcomes (KDIGO).
@en
Definition and classification ...... ase: Improving Global Outcomes
@nl
P2093
P1433
P1476
Definition and classification ...... oving Global Outcomes (KDIGO).
@en
P2093
Adeera Levin
Andrew S Levey
Dick De Zeeuw
Garabed Eknoyan
Jerome Rossert
Kai-Uwe Eckardt
Norbert Lameire
Thomas H Hostetter
Yusuke Tsukamoto
P304
P356
10.1111/J.1523-1755.2005.00365.X
P407
P50
P577
2005-06-01T00:00:00Z
P5875
P6179
1001663676